top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Suzanne Crowe Biography and Net Worth

Director of AVITA Medical

Professor Suzanne Crowe AO, has served as a Non-Executive Director of AVITA Medical since January 2016. Australian-based, she is a physician-scientist and ASX/Nasdaq-listed company director with expertise in supporting companies with their medical and scientific strategies. A Fellow of the Australian Institute of Company Directors, she is currently a Non-Executive Director of St Vincent’s Health Australia Ltd, the country’s largest not-for-profit health and aged care provider, and Non-Executive Director of Sonic Healthcare Ltd, a large global medical diagnostic company. She was appointed Emeritus Professor, Monash University, Melbourne in 2020. After 35 years at both, she has recently retired from the Burnet Institute, having served as Associate Director Clinical Research, and the university-affiliated Alfred Hospital Melbourne, where she held the appointment of Senior Specialist Physician in Infectious Diseases. She was appointed as Officer of the Order of Australia in June 2020 in recognition of her distinguished services to health, clinical governance, biomedical research and education.

How do I contact Suzanne Crowe?: The corporate mailing address for Dr. Crowe and other AVITA Medical executives is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. AVITA Medical can also be reached via phone at (833) 462-8482 and via email at [email protected]. Learn More on Suzanne Crowe's contact information.
Has Suzanne Crowe been buying or selling shares of AVITA Medical?: Suzanne Crowe has not been actively trading shares of AVITA Medical within the last three months. Most recently, on Monday, September 20th, Suzanne Crowe bought 1,066 shares of AVITA Medical stock. The stock was acquired at an average cost of $17.08 per share, with a total value of $18,207.28. Learn More on Suzanne Crowe's trading history.
Who are AVITA Medical's active insiders?: AVITA Medical's insider roster includes Suzanne Crowe (Director), and Michael Perry (CEO). Learn More on AVITA Medical's active insiders.
Are insiders buying or selling shares of AVITA Medical?: In the last year, AVITA Medical insiders bought shares 6 times. They purchased a total of 9,450 shares worth more than $147,997.50. In the last year, insiders at the sold shares 3 times. They sold a total of 8,156 shares worth more than $116,517.03. The most recent insider tranaction occured on December, 26th when CEO James Corbett sold 1,445 shares worth more than $19,204.05. Insiders at AVITA Medical own 2.1% of the company. Learn More about insider trades at AVITA Medical.
Information on this page was last updated on 12/26/2023.

Suzanne Crowe Insider Trading History at AVITA Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/20/2021	Buy	1,066	$17.08	$18,207.28

Suzanne Crowe Buying and Selling Activity at AVITA Medical

AVITA Medical Company Overview

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Today's Range

Now: $8.57

$8.53

$9.27

50 Day Range

MA: $15.08

$8.55

$18.31

2 Week Range

Now: $8.57

$8.46

$21.70

Volume

149,342 shs

Average Volume

211,645 shs

Market Capitalization

$220.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.33